Patients who don't speak English face additional obstacles during their cancer journey but family, caregivers and the law are on their side.
Patients who don't speak English face additional obstacles during their cancer journey but family, caregivers and the law are on their side.
Jennifer Ortiz Is the 1st runner-up recipient of the 2023 EBCI National HOPE Award.
Thanks to Kiyatec’s 3D Predict, cancer patients with elevated HCG levels and their physicians are seeing game-changing results.
EBCI focuses on brain disease education, outreach, and awareness to this patient community and their families...worldwide.
Alyssa Gohra is the 2023 National Hope Award winner.
National Cancer Institute (NCI) researchers are conducting a study of patients with IDH-mutated gliomas.
The End Brain Cancer Initiative is pleased to announce that Alyssa Gohra is the 2023 National HOPE Award winner.
Imvax is conducting a new phase 2b clinical study, with a combination immunotherapy, for newly diagnosed patients with glioblastoma.
The Pacific Neuroscience Institute has created a series of videos featuring patients and caregivers discussing brain tumor treatments.
The FDA is drafting new guidance on the use of external data in lieu of placebos in clinical trials. Please support this change.
Each May the EndBrainCancer Initiative, in Partnership with Novocure, has presented the HOPE award to brain cancer patients who deeply inspire us with their courage and story.
If you have been diagnosed with rGBM (first recurrence only), would you like to participate in a PAID short interview?
